Cargando…

The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis

OBJECTIVE: To systematically evaluate the effects of lead therapies on percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI). METHODS: A randomized controlled trial (RCT) in the CNKI, Wanfang, VIP, ProQuest, PubMed, Cochrane Library, Scopus, and Web of Science databases wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Meixia, Ding, Yi, Chen, Kang, He, Yanwen, Zhang, Yukun, Zhuo, Yue, Zhuang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681617/
https://www.ncbi.nlm.nih.gov/pubmed/38013356
http://dx.doi.org/10.1097/MD.0000000000036183
_version_ 1785150831369125888
author Sun, Meixia
Ding, Yi
Chen, Kang
He, Yanwen
Zhang, Yukun
Zhuo, Yue
Zhuang, He
author_facet Sun, Meixia
Ding, Yi
Chen, Kang
He, Yanwen
Zhang, Yukun
Zhuo, Yue
Zhuang, He
author_sort Sun, Meixia
collection PubMed
description OBJECTIVE: To systematically evaluate the effects of lead therapies on percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI). METHODS: A randomized controlled trial (RCT) in the CNKI, Wanfang, VIP, ProQuest, PubMed, Cochrane Library, Scopus, and Web of Science databases was searched until January 2023. Two researchers strictly screened and checked the included literature, extracted relevant data, and used the Cochrane Manual to assess the risk quality of the literature. Using RevMan 5.3 software, Meta-analysis of 4 main outcome measures [cardiac function-related indicators, 6-minute walking distance (6 MWT), quality of life (SF-36), Seattle angina pectoris scale (SAQ)], and 3 secondary outcome measures [adverse event incidence, death incidence, and readmission rate]. RESULTS: 22 studies were finally included with 1754 subjects, but the overall quality of the included studies was not high. The results of the meta-analysis showed that, in the cardiac function-related indicators compared to controls, improved left ventricular ejection fraction (LVEF) index (MD = 1.42, 95%CI [−0.94, 3.79], P < .00001); however, compared with the Baduanjin group, Tai Chi ball + Baduanjin group and control group, there was no significant difference (P > .05); compared with the control group, the guidance therapy group improved the left ventricular end-diastolic volume (LVEDV) index (MD = −4.67, 95%CI [−6.8, −2.71], P < .00001). In comparison, the lead group improved the 6 MWT (MD = 69.44, 95%CI [30.12, 108.76], P < .00001); the SF-36 score (MD = 10.05, 95%CI [8.68, 11.42], P < .00001])and the SAQ score (MD = 6.2, 95%CI [3.97, 8.44], P < .00001). Among the secondary outcome measures, the incidence of adverse events was statistically significant (RR = 0.17, 95%CI [0.1, 0.32], P < .00001); statistically significant (RR = 0.29, 95%CI (0.1, 0.87), P < .00001); readmission (RR = 0.39, 95%CI [0.17, 0.87, 0.89], P < .00001). CONCLUSION: Based on the current study, combining conventional therapy/ exercise or using simple lead therapy after PCI can improve the treatment effect and improve the quality of life.
format Online
Article
Text
id pubmed-10681617
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-106816172023-11-24 The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis Sun, Meixia Ding, Yi Chen, Kang He, Yanwen Zhang, Yukun Zhuo, Yue Zhuang, He Medicine (Baltimore) 3200 OBJECTIVE: To systematically evaluate the effects of lead therapies on percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI). METHODS: A randomized controlled trial (RCT) in the CNKI, Wanfang, VIP, ProQuest, PubMed, Cochrane Library, Scopus, and Web of Science databases was searched until January 2023. Two researchers strictly screened and checked the included literature, extracted relevant data, and used the Cochrane Manual to assess the risk quality of the literature. Using RevMan 5.3 software, Meta-analysis of 4 main outcome measures [cardiac function-related indicators, 6-minute walking distance (6 MWT), quality of life (SF-36), Seattle angina pectoris scale (SAQ)], and 3 secondary outcome measures [adverse event incidence, death incidence, and readmission rate]. RESULTS: 22 studies were finally included with 1754 subjects, but the overall quality of the included studies was not high. The results of the meta-analysis showed that, in the cardiac function-related indicators compared to controls, improved left ventricular ejection fraction (LVEF) index (MD = 1.42, 95%CI [−0.94, 3.79], P < .00001); however, compared with the Baduanjin group, Tai Chi ball + Baduanjin group and control group, there was no significant difference (P > .05); compared with the control group, the guidance therapy group improved the left ventricular end-diastolic volume (LVEDV) index (MD = −4.67, 95%CI [−6.8, −2.71], P < .00001). In comparison, the lead group improved the 6 MWT (MD = 69.44, 95%CI [30.12, 108.76], P < .00001); the SF-36 score (MD = 10.05, 95%CI [8.68, 11.42], P < .00001])and the SAQ score (MD = 6.2, 95%CI [3.97, 8.44], P < .00001). Among the secondary outcome measures, the incidence of adverse events was statistically significant (RR = 0.17, 95%CI [0.1, 0.32], P < .00001); statistically significant (RR = 0.29, 95%CI (0.1, 0.87), P < .00001); readmission (RR = 0.39, 95%CI [0.17, 0.87, 0.89], P < .00001). CONCLUSION: Based on the current study, combining conventional therapy/ exercise or using simple lead therapy after PCI can improve the treatment effect and improve the quality of life. Lippincott Williams & Wilkins 2023-11-24 /pmc/articles/PMC10681617/ /pubmed/38013356 http://dx.doi.org/10.1097/MD.0000000000036183 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 3200
Sun, Meixia
Ding, Yi
Chen, Kang
He, Yanwen
Zhang, Yukun
Zhuo, Yue
Zhuang, He
The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis
title The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis
title_full The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis
title_fullStr The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis
title_full_unstemmed The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis
title_short The therapeutic efficacy of guided therapy for PCI after acute myocardial infarction: A meta-analysis
title_sort therapeutic efficacy of guided therapy for pci after acute myocardial infarction: a meta-analysis
topic 3200
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681617/
https://www.ncbi.nlm.nih.gov/pubmed/38013356
http://dx.doi.org/10.1097/MD.0000000000036183
work_keys_str_mv AT sunmeixia thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT dingyi thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT chenkang thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT heyanwen thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT zhangyukun thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT zhuoyue thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT zhuanghe thetherapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT sunmeixia therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT dingyi therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT chenkang therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT heyanwen therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT zhangyukun therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT zhuoyue therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis
AT zhuanghe therapeuticefficacyofguidedtherapyforpciafteracutemyocardialinfarctionametaanalysis